An alternative to opioids? Optimism over new ‘non-addictive’ analgesic

The US Food and Drug Administration has approved the first new drug for moderate to severe acute pain in 25 years.
Called suzetrigine, the first-in-class agent holds the promise of analgesia without any risk of addiction.
Professor Ric Day, a clinical pharmacologist at UNSW Sydney, calls it an exciting advance following “lots of drugs that have come along over the years related to opioids”.
“People said they were not going to cause dependence, but we’ve been disappointed over and over again.”